United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brown & burk uk ltd - amoxicillin trihydrate - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brown & burk uk ltd - amoxicillin trihydrate - oral capsule - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flamingo pharma (uk) ltd - amoxicillin trihydrate - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flamingo pharma (uk) ltd - amoxicillin trihydrate - oral capsule - 500mg

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin sodium 1.06 g equivalent to amoxicillin 1 g - as part of a 5:1 mix;  ; potassium clavulanate 238.3mg equivalent to clavulanic acid 200 mg - as part of a 5:1 mix - powder for injection - 1000/200mg - active: amoxicillin sodium 1.06 g equivalent to amoxicillin 1 g - as part of a 5:1 mix   potassium clavulanate 238.3mg equivalent to clavulanic acid 200 mg - as part of a 5:1 mix - short term treatment of common bacterial infections such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media; lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia; genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections; skin and soft tissue infections; bone and joint infections: e.g. osteomyelitis; other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections. prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery. infections caused by amoxicillin susceptible organisms are amenable to amoxicillin/clavulanic acid treatment due to its amoxicillin content. mixed infections caused by amoxicillin susceptible organisms in conjunction with amoxicillin/clavulanic acid susceptible beta-lactamase-producing organisms may therefore be treated by amoxicillin/clavulanic acid.

Ireland - English - HPRA (Health Products Regulatory Authority)

fannin limited - amoxicillin sodium; clavulanic acid (in the form of potassium clavulanate) - powder for solution for injection/infusion - 500 mg/100 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

fannin limited - amoxicillin sodium; clavulanic acid (in the form of potassium clavulanate) - powder for solution for injection/infusion - 1000 mg/200 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - capsule - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - capsule - 500mg - amoxicillin (amoxicillin trihydrate) 500mg - aminopenicillins

Canada - English - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - granules for suspension - 125mg - amoxicillin (amoxicillin trihydrate) 125mg - aminopenicillins